Hany S Bedair1,2, Akhil Katakam1,2, Yehia H Bedeir3, David Yeroushalmi4, Ran Schwarzkopf4. 1. Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA. 2. Kaplan Joint Center, Newton-Wellesley Hospital, Newton, MA, USA. 3. Department of Orthopaedic Surgery, University of Alexandria, Alexandria, Egypt. 4. Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, New York, NY, USA.
Abstract
OBJECTIVE: The purpose of this study was to investigate whether immediate or delayed tailored DAIR treatment based on microbial species is the optimal treatment for acute post-operative periprosthetic joint infection (PJI). METHODS: A multicenter retrospective study was conducted to identify patients who underwent debridement, antibiotics, and implant retention (DAIR) for PJI. Decision analysis modeling was employed to determine the treatment strategy that yielded the greatest patient outcome. RESULTS: 316 patients who underwent DAIR for PJI were identified. CONCLUSION: The decision analysis model determined that the optimal treatment strategy is to perform an immediate DAIR to achieve the greatest QALY outcomes in TKA and THA patients with acute PJI.
OBJECTIVE: The purpose of this study was to investigate whether immediate or delayed tailored DAIR treatment based on microbial species is the optimal treatment for acute post-operative periprosthetic joint infection (PJI). METHODS: A multicenter retrospective study was conducted to identify patients who underwent debridement, antibiotics, and implant retention (DAIR) for PJI. Decision analysis modeling was employed to determine the treatment strategy that yielded the greatest patient outcome. RESULTS: 316 patients who underwent DAIR for PJI were identified. CONCLUSION: The decision analysis model determined that the optimal treatment strategy is to perform an immediate DAIR to achieve the greatest QALY outcomes in TKA and THA patients with acute PJI.
Authors: Benjamin Zmistowski; Craig Della Valle; Thomas W Bauer; Konstantinos N Malizos; Abbas Alavi; Hani Bedair; Robert E Booth; Peter Choong; Carl Deirmengian; Garth D Ehrlich; Anil Gambir; Ronald Huang; Yair Kissin; Hideo Kobayashi; Naomi Kobayashi; Veit Krenn; Drago Lorenzo; S B Marston; Geert Meermans; Javier Perez; J J Ploegmakers; Aaron Rosenberg; Peter Thomas; Stephan Tohtz; Jorge A Villafuerte; Peter Wahl; Frank-Christiaan Wagenaar; Eivind Witzo Journal: J Orthop Res Date: 2014-01 Impact factor: 3.494
Authors: Kenneth L Urish; Andrew G Bullock; Alexander M Kreger; Neel B Shah; Kwonho Jeong; Scott D Rothenberger Journal: J Arthroplasty Date: 2017-11-21 Impact factor: 4.757
Authors: C E Marculescu; E F Berbari; A D Hanssen; J M Steckelberg; S W Harmsen; J N Mandrekar; D R Osmon Journal: Clin Infect Dis Date: 2006-01-05 Impact factor: 9.079
Authors: George Grammatopoulos; Benjamin Kendrick; Martin McNally; Nicholas A Athanasou; Bridget Atkins; Peter McLardy-Smith; Adrian Taylor; Roger Gundle Journal: J Arthroplasty Date: 2017-03-06 Impact factor: 4.757
Authors: Steven M Kurtz; Edmund Lau; Jordana Schmier; Kevin L Ong; Ke Zhao; Javad Parvizi Journal: J Arthroplasty Date: 2008-04-10 Impact factor: 4.757
Authors: Justin S Cummins; Ivan M Tomek; Stephen R Kantor; Ove Furnes; Lars Birger Engesaeter; Samuel R G Finlayson Journal: J Bone Joint Surg Am Date: 2009-03-01 Impact factor: 5.284